Spectrum of hepatitis B infection in Southern India: A cross-sectional analysis

摘要

Background and Aim: Hepatitis B virus (HBV)-related liver disease is not an uncommon problem in India. There are veryfew reports on pattern of chronic HBV infection from South India. The aim of the present study was to determine the spectrumof chronic HBV infection among patients attending the liver clinic in a tertiary referral center. Materials and Methods:Hepatitis B surface antigen (HBsAg) positive patients registered in the liver clinic between July 2010 and March 2011 wereincluded in the study. All patients had baseline liver function tests, serological markers for HBV infection (hepatitis B e antigen[HBeAg], anti-HBe, anti-HBc total, and anti-HBc IgG, and HBV DNA quantification), serum alpha-fetoprotein, andultrasound. Based on the viral profile and transaminase levels and ultrasound findings, patients were categorized asimmunotolerant, inactive carriers, immune clearance and reactivation phase, and chronic liver disease with or withouthepatocellular carcinoma. Results: Majority of the patients were asymptomatic and incidentally detected during blooddonation camps, master health checkup (MHC), or during initial screening. Almost 40% of patients were either in immuneinactive phase or had features of chronic liver disease. In the immunotolerant phase (24 patients), women were a decadeyounger than their male counterparts. Alanine aminotransferase (ALT) levels were similar in both HBeAg-positive and negativepatients. The mean HBV DNA values were significantly high in HBeAg-positive men and women. In the immune inactive phase(58 patients), there were only three patients who were HBeAg positive. The ALT levels were in the normal range. HBV DNAvalues were low or not detectable. Among patients with elevated ALT and HBV DNA levels (immune clearance/immunereactive) (fifty patients), the mean ALT levels were higher in HBeAg-negative patients. HBV DNA quantity was significantlyhigh in patients who were HBeAg positive. Conclusion: A significant proportion of HBsAg-positive patients is in inactive or inimmunotolerant phase and do not require treatment. Patients with elevated ALT and HBV DNA levels need further evaluationto categorize them into immune clearance or immune reactive phase.